[Evaluation of the effect of spinonolactone on myasthenia gravis using a double blind test].
D000328:Adult; D002800:Cholinesterase Inhibitors / Q000008:administration & dosage*; D005260:Female; D006801:Humans; D009157:Myasthenia Gravis / Q000188:drug therapy*; D010919:Placebos; D013148:Spironolactone / Q000008:administration & dosage*
D002800:Cholinesterase Inhibitors; D010919:Placebos; D013148:Spironolactone